Результати пошуку - Shoshana Revel‐Vilk

Уточнити результати
  1. 1
    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review

    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review за авторством Shoshana Revel‐Vilk, Maria Fuller, Ari Zimran

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  2. 2
    How we manage Gaucher Disease in the era of choices

    How we manage Gaucher Disease in the era of choices за авторством Shoshana Revel‐Vilk, Jeff Szer, Atul Mehta, Ari Zimran

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  3. 3
    Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease

    Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease за авторством Shoshana Revel‐Vilk, Anthony K.C. Chan, Mary Bauman, Patricia Massicotte

    Опубліковано 2003
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy

    A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replaceme... за авторством Noa Hurvitz, Tama Dinur, Shoshana Revel‐Vilk, Samuel Agus, Marc Berg, Ari Zimran, Yaron Ilan

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    At what age can human oocytes be obtained?

    At what age can human oocytes be obtained? за авторством Ariel Revel, Shoshana Revel‐Vilk, Einat Aizenman, Anat Porat‐Katz, Anat Safran, Assaf Ben‐Meir, Michael Weintraub, Michal Shapira, Hanna Achache, Neri Laufer

    Опубліковано 2008
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach

    IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach за авторством Polina Stepensky, Michael Weintraub, A. Yanir, Shoshana Revel‐Vilk, Frank Krux, Kirsten Huck, René Martin Linka, Avraham Shaag, Orly Elpeleg, Arndt Borkhardt, Igor Resnick

    Опубліковано 2010
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease

    Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease за авторством Noa Hurvitz, Tama Dinur, Michal Becker‐Cohen, Claudia Cozma, Marina Hovakimyan, Sebastian Oppermann, Laura Demuth, Arndt Rolfs, Aya Abramov, Ari Zimran, Shoshana Revel‐Vilk

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?

    Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm? за авторством Tama Dinur, Peter Bauer, Christian Beetz, Guido Kramp, Claudia Cozma, Marius‐Ionuţ Iuraşcu, Michal Becker‐Cohen, Majdolen Istaiti, Arndt Rolfs, Ari Zimran, Shoshana Revel‐Vilk

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1

    Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1 за авторством Andrea Dardis, Helen Michelakakis, Paula Rozenfeld, Ksenija Fumić, Jasenka Wagner, Eleonora Pavan, Maria Fuller, Shoshana Revel‐Vilk, Derralynn Hughes, Timothy M. Cox, Johannes M. F. G. Aerts

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    Safety analysis of self-administered enzyme replacement therapy using data from the Fabry Outcome and Gaucher Outcome Surveys

    Safety analysis of self-administered enzyme replacement therapy using data from the Fabry Outcome and Gaucher Outcome Surveys за авторством Shoshana Revel‐Vilk, Uma Ramaswami, Guillem Pintos‐Morell, Derralynn Hughes, Kathy Nicholls, Ricardo Reisin, Roberto Giugliani, Özlem Göker-Alpan, Majdolen Istaiti, Aidan Gill, Maurizio Scarpa, Jaco Botha

    Опубліковано 2025
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  11. 11
    Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study

    Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study за авторством Shoshana Revel‐Vilk, Royston Mansfield, Neta Feder-Krengel, Noya Machtiger-Azoulay, David J. Kuter, Jeff Szer, Hanna Rosenbaum, David Cavalcanti Ferreira, Noa Ruhrman‐Shahar, Michael P. Wajnrajch, Ari Zimran

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  12. 12
    GBA1-Associated Parkinson’s Disease Is a Distinct Entity

    GBA1-Associated Parkinson’s Disease Is a Distinct Entity за авторством Aliaksandr Skrahin, Mia Horowitz, Majdolen Istaiti, Volha Skrahina, Jan Lukáš, Gilad Yahalom, Mikhal E. Cohen, Shoshana Revel‐Vilk, Özlem Göker-Alpan, Michal Becker‐Cohen, Sharon Hassin‐Baer, Per Svenningsson, Arndt Rolfs, Ari Zimran

    Опубліковано 2024
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  13. 13
    Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia

    Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia за авторством Anja J. Gerrits, Emily Leven, Andrew L. Frelinger, Sophie L. Brigstocke, Michelle A. Berny‐Lang, W. Beau Mitchell, Shoshana Revel‐Vilk, Hannah Tamary, Sabrina L. Carmichael, Marc R. Barnard, Alan D. Michelson, James B. Bussel

    Опубліковано 2015
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  14. 14
    Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness

    Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness за авторством Neil A. Goldenberg, Anthony A. Sochet, Manuela Albisetti, Tina Biss, Mariana Bonduel, Julie Jaffray, Graeme MacLaren, Paul Monagle, Sarah H. O’Brien, Leslie Raffini, Shoshana Revel‐Vilk, Nongnuch Sirachainan, Suzan Williams, Ayesha Zia, Christoph Male

    Опубліковано 2020
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  15. 15
    Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry

    Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry за авторством Deborah Elstein, Nadia Belmatoug, Bruno Bembi, Patrick Deegan, Diego Fernandez‐Sasso, Pilar Giraldo, Özlem Göker-Alpan, Derralynn Hughes, Heather Lau, Elena Lukina, Shoshana Revel‐Vilk, Ida Vanessa Döederlein Schwartz, Majdolen Istaiti, Jaco Botha, Noga Gadir, Jörn Schenk, Ari Zimran

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  16. 16
    Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans

    Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans за авторством Cyrill Schipp, Schafiq Nabhani, K. Bienemann, Natalia Simanovsky, Shlomit Kfir-erenfeld, Nathalie Assayag-Asherie, Prasad T. Oommen, Shoshana Revel‐Vilk, Andrea Hönscheid, Michael Gombert, Sebastian Ginzel, Daniel W. Schafer, Hans-Juergen Laws, Eitan Yefenof, Bernhard Fleckenstein, Arndt Borkhardt, Polina Stepensky, Ute Fischer

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Carta
    Додати у Вибране
    Збережено в:
  17. 17
    Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population

    Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population за авторством Orna Steinberg‐Shemer, Tracie Goldberg, Joanne Yacobovich, Carina Levin, Ariel Koren, Shoshana Revel‐Vilk, Tal Ben‐Ami, Amir A. Kuperman, Vered Shkalim Zemer, Amos Toren, Joseph Kapelushnik, Ayelet Ben‐Barak, Hagit Miskin, Tanya Krasnov, Sharon Noy‐Lotan, Orly Dgany, Hannah Tamary

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  18. 18
    Upgrading the evidence for the use of ambroxol in Gaucher disease and <scp>GBA</scp> related Parkinson: Investigator initiated registry based on real life data

    Upgrading the evidence for the use of ambroxol in Gaucher disease and <scp>GBA</scp> related Parkinson: Investigator initiated registry based on real life data за авторством Majdolen Istaiti, Shoshana Revel‐Vilk, Michal Becker‐Cohen, Tama Dinur, Uma Ramaswami, Daniela Castillo‐García, Magdalena Cerón‐Rodríguez, Alicia Chan, Predrag Rodić, Radka Tincheva, Walla Al‐Hertani, Beom Hee Lee, Chia‐Feng Yang, Beata Kieć‐Wilk, Agata Fiumara, Bárbara Rubio, Ari Zimran

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  19. 19
    Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency

    Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency за авторством Polina Stepensky, Anne Rensing‐Ehl, Ruth Gather, Shoshana Revel‐Vilk, Ute Fischer, Schafiq Nabhani, Fabian Beier, Tim H. Brümmendorf, Sebastian Fuchs, Simon Zenke, Elke Firat, Vered Molho Pessach, Arndt Borkhardt, Mirzokhid Rakhmanov, Bärbel Keller, Klaus Warnatz, Hermann Eibel, Gabriele Niedermann, Orly Elpeleg, Stephan Ehl

    Опубліковано 2014
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  20. 20
    GNE variants causing autosomal recessive macrothrombocytopenia without associated muscle wasting

    GNE variants causing autosomal recessive macrothrombocytopenia without associated muscle wasting за авторством Shoshana Revel‐Vilk, Ela Shai, Ernest Turro, Nivin Jahshan, Esti Hi-Am, Galia Spectre, Hagit Daum, Yossef Kalish, Karina Althaus, Andreas Greinacher, Chaim Kaplinsky, Shai Izraeli, Rutendo Mapeta, Sri V. V. Deevi, Danuta Jarocha, Willem H. Ouwehand, Kate Downes, Mortimer Poncz, David Varon, Michele P. Lambert

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Carta
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: